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The lack of rapid antibiotic susceptibility tests adversely affects the treatment of bacterial infec-
tions and contributes to increased prevalence of multidrug resistant bacteria. Here, we describe an
all-electrical approach that allows for ultra-sensitive measurement of growth signals from only tens
of bacteria in a microfluidic device. Our device is essentially a set of microfluidic channels, each with
a nano-constriction at one end and cross-sectional dimensions close to that of a single bacterium.
Flowing a liquid bacteria sample (e.g., urine) through the microchannels rapidly traps the bacteria
in the device, allowing for subsequent incubation in drugs. We measure the electrical resistance of
the microchannels, which increases (or decreases) in proportion to the number of bacteria in the
microchannels. The method and device allow for rapid antibiotic susceptibility tests in about two
hours. Further, the short-time fluctuations in the electrical resistance during an antibiotic suscep-
tibility test are correlated with the morphological changes of bacteria caused by the antibiotic. In
contrast to other electrical approaches, the underlying geometric blockage effect provides a robust
and sensitive signal, which is straightforward to interpret without electrical models. The approach
also obviates the need for a high-resolution microscope and other complex equipment, making it
potentially usable in resource-limited settings.
KEYWORDS: Antibiotic Susceptibility Testing, Growth and Morphology, Antibiotic Resistance,
Microfluidics.
INTRODUCTION
Multidrug resistant bacteria pose an increasingly seri-
ous threat to global public health [1]. While drug resis-
tance in bacteria occurs naturally due to random genetic
mutations and genetic exchanges between strains and
species, it is accelerated partly because of inappropriate
antibiotic use [2]. Strategies, such as rapid point-of-care
antibiotic susceptibility testing, can facilitate targeted
antibiotic treatments and impede the spread of antibi-
otic resistance [3–5]. However, standard antibiotic sus-
ceptibility tests (ASTs) suffer from a lengthy cell culture
step and take 24-48 hours to complete [6, 7]. Given the
risks associated with delayed therapy, physicians typi-
cally have little choice but to empirically prescribe broad-
spectrum antibiotics while waiting for the microbiological
analysis [8, 9]. The development of rapid ASTs would im-
prove morbidity and mortality and could help reduce the
prevalence of multidrug resistant bacteria [10].
The “gold standard ASTs are phenotypic and measure
the growth of bacteria in the presence of antibiotics on
solid agar plates or in liquid solutions. After incubation
for 24-48 hours, the susceptibility of the bacterial strain
can be determined from the growth size and patterns
on the plate or the optical density (OD) of the liquid
solution [4]. Polymerase chain reaction (PCR) provides
the quintessential genotypic AST [11]. PCR directly de-
tects the resistance gene(s) from a very small bacteria
sample and hence is quite rapid. However, it still has
limited utility, because only a few resistance genes are
firmly associated with phenotypic antibiotic resistance
and newly-acquired resistance mechanisms may not be
detectable [12].
Given the limitations of mainstay ASTs, there is a sig-
nificant push for developing novel methods that can in-
form on bacterial resistance at early stages of cell growth.
These novel and emerging ASTs typically employ mi-
crofluidics and microdevices because these devices allow
for effective sample use and are sensitive to small sig-
nals [13]. State-of-the-art approaches isolating bacteria
in nanodroplets [14, 15], on microbeads [16], inside mi-
crofluidic channels [17–21], and on and inside microme-
chanical resonators [22] have all allowed testing on a few
cells and even single cells. These approaches involve a va-
riety of transduction mechanisms to access the response
of bacteria to antibiotics, including high-resolution imag-
ing [14, 15, 17, 18], mechanical [16, 22], impedance [19],
and electrochemical sensing [20, 21]. More recently, high-
resolution imaging of growth of bacteria trapped in mi-
crochannels [17, 18] have allowed for ASTs in under an
hour [17]. While ingenious, each method comes with
some drawbacks [23], and it remains to be seen whether
or not any will achieve sufficient robustness needed for
routine clinical practice.
Our method and device build on the positive attributes
of recent approaches and address some of their short-
comings. As in earlier work [17, 18], we trap and incu-
bate cells in a microfluidic channel; our measurement,
however, is entirely electrical. The effect underlying the
bacterial growth signal in our device is simple geometric
blockage: as bacteria grow (or die) in the microchan-
nel, the channel resistance to electrical current increases
(decreases). The change in the number of bacteria in the
device, therefore, is directly proportional to the measured
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FIG. 1. Microfluidic device and its principle of operation. (A) Schematic of the device. The PDMS slab embedded with a
two-layer microfluidic channel (inset) is bonded onto a glass substrate with deposited thin film electrodes. At the center is
the detection region, which features an array of ten microchannels (2-µm height and 2-µm width) in parallel. These central
microchannels are connected to two reservoirs via 100-µm-height macrochannels; the two reservoirs are connected to sample
lines. (B) Microscope image (63×) of trapped bacteria (K. pneumoniae) in the microchannels. Scale bar is 5 µm. Bottom
illustration shows the constriction for capturing bacteria. A four-wire electrical resistance measurement is used. Growth and
morphological changes of bacteria in the microchannel alter the effective electrical resistance of the microchannel. (C ) Number
of trapped bacteria (K. pneumoniae) in the microchannels as a function of sample loading time for cultures with different cell
concentrations. Inset shows the electrical resistance change as a function of the number of bacteria in the microchannel from
three nominally identical devices. The linear fit gives the resistance change per added bacterium of ∼ 2.5 kΩ; the large data
points correspond to binned average values.
resistance change, and is available without fits to multi-
parameter circuit models [24]. The device can directly
be used with urine and probably other bodily fluids, pro-
vided that the fluids contain ions. Another interesting
and useful attribute of the approach is that it provides
electrical clues on how bacteria respond to antibiotics.
We observe different short-time fluctuation patterns in
electrical signals coming from bacteria incubated in bac-
teriostatic and bactericidal antibiotics, suggesting that
morphological changes are also encoded into the electrical
signals. In cases where both growth and morphological
analysis are required, this unique feature may be useful
[25–27]. We re-emphasize that microscopy is not required
in our approach; at the current stage of development, it
is used only as a validation tool.
RESULTS
Device Design and Loading
The design and basic principle of operation of the
microfluidic device is shown in Fig. 1. The device is
essentially a continuous polydimethylsiloxane (PDMS)
channel on a glass substrate with thin metal film elec-
trodes. At the center, the channel tapers down into
ten smaller microchannels each with linear dimensions
l × w × h ≈ 100 × 2 × 2 µm3. On one end of each
of these parallel microchannels, a physical constriction
(l × w × h ≈ 5× 0.8× 2 µm3) is fabricated for trapping
bacteria from a flowing sample (Fig. 1B). During op-
eration, a pressure-driven flow of a bacteria solution is
established through the microchannels from the inlet to
the outlet (Fig. 1A and B). The bacteria in the solution
cannot pass through the constriction and are trapped
as shown in the optical microscope image in Fig. 1B.
In the experiments, the electrical resistance of the mi-
crochannel region is monitored using a 4-wire measure-
ment (Fig. 1B). When the microchannels are filled with
just media with no bacteria, i.e., empty, their typical re-
sistances are Rem ≈ 3 MΩ± 30 kΩ.
At the start of each experiment, the bacteria sample is
loaded into the microfluidic device from the inlet by keep-
ing the inlet at a pressure ∆p ∼ 10 kPa above the outlet.
Fig. 1C shows the number of trapped cells as a function
of time for Klebsiella pneumoniae suspensions at differ-
ent bacteria concentrations in the range from 5× 103 to
2 × 107 CFU/mL. Approximately 60 bacteria are cap-
tured in ∼ 30 min at 5×105 CFU/mL, which is close to
the cell density in the urine of a UTI patient [28]. At
the most dilute bacteria concentration (5×103), we only
trapped a few bacteria over the 30 min period. The trap-
ping efficiency at low concentration could be improved by
increasing ∆p or the number of microchannels.
The inset of Fig. 1C shows the electrical signal, as bac-
teria number increases in the microchannels. Here, we
3show the resistance increase ∆R from the empty state,
as a function of the number n of bacteria in the mi-
crochannels from three separate experiments using differ-
ent microchannels with identical nominal linear dimen-
sions. The increase in ∆R with n can be understood in
simple terms. The microchannel filled with the media is
essentially an electrical conductor due to the ions in the
buffer. The bacteria in the microchannel “clog” the mi-
crochannel and reduce the effective cross-section, thereby
increasing the resistance. The data follow a linear trend,
with a resistance change of ∆R
(KP )
1 ≈ 2.5 ± 0.3 kΩ per
bacterium (K. pneumoniae) added. Similar experiments
(SI Appendix, Fig. S3) give ∆R
(EC)
1 ≈ 3.7± 0.3 kΩ and
∆R
(SS)
1 ≈ 3.5 ± 1.1 kΩ for Escherichia coli and Staphy-
lococcus saprophyticus, respectively. An estimate using
simple geometric arguments for K. pneumoniae provides
∆R1 ∼ 1.5 kΩ, not far from the measured value (SI Ap-
pendix, Supplemental Materials and Methods). These
∆R1 values provide a good calibration for the experi-
ments and allow us to the estimate that ∼ 20 cells are
needed to to perform a conclusive antibiotic susceptibil-
ity test due to the long-term electrical drifts.
Since we do not use very high pressures during loading,
bacteria occasionally accumulate at other locations in the
device, particularly at lithographical edges and at the en-
trances of microchannels. When this happens, the mea-
sured resistances to correspond to larger bacteria num-
bers than counted from microscope image. The electrical
signal is quite robust against such non-ideal occurrences.
First, the geometry ensures that the largest resistance
signals come from the central detection region (SI Ap-
pendix, Supplemental Materials and Methods). Second,
all bacteria inside the device, regardless of where they
are, generate coherent electrical signals of cell growth or
cell death. Third, any contaminants that partially block
the device and do not change over time just result in
time-independent background signals.
Electrical Monitoring of Bacterial Growth
We first perform an electrical measurement of bacte-
ria growth. We record the device resistance R(t) as a
function of time. We then determine the normalized
time-dependent resistance change defined as ∆R(t)∆R(0) =
R(t)−Rem
R(0)−Rem , where R(0) and Rem respectively are the de-
vice resistance right after loading (t = 0) and without
bacteria (empty). From Fig. 1C inset above, we expect
that ∆R(t)∆R(0) ≈ n(t)n(0) , where n(t) is the number of bacteria
in the microchannels. Fig. 2A shows the normalized re-
sistance for motile E. coli as a function of time obtained
in Phosphate-buffered saline (PBS) at 37◦C and Luria-
Bertani (LB) broth at 23◦C and 37◦C. After bacteria are
loaded and during the measurement, ∆p ≈ 0.5 kPa is
applied to maintain a constant flow of nutrients. Shown
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FIG. 2. Electrical detection of bacteria growth. (A) Growth
curves for E. coli in PBS at 37◦C (black) and LB broth at
23◦C (magenta) and 37◦C (red). Inset shows optical images of
E. coli in the microchannels in LB broth at 37◦C at different
points in time. The scale bars are 5 µm. (B) Growth curves
for E. coli (red), K. pneumoniae (green), and S. saprophyticus
(blue) at 37◦C in LB broth. Each data trace is the average
of three independent experiments. (Error bars for the growth
data are shown in Fig. 3.) Inset shows the doubling time.
Error bars represent standard deviations.
in Fig. 2A inset are optical microscope images of the
trapped E. coli taken at t = 0, 20, 40 mins during the
electrical measurement in LB broth at 37◦C (also see SI
Appendix, Movie S1).
Fig. 2B shows similar growth curves for gram-positive
and gram-negative bacteria. K. pneumoniae and S.
saprophyticus are non-motile and are easily trapped in
the microchannels by a pressure-driven flow; E. coli is
motile but unlikely to reverse its direction and exit the
tight microchannel once it enters. The electrical resis-
tance changes are all close to exponentials: ∆R(t)∆R(0) ≈
4n(t)
n(0) ≈ ert, with the growth rate r providing the dou-
bling time td =
ln 2
r for each strain. The inset shows td
values obtained from linear fits to the natural logarithms
of the growth curves. The td we measure are longer than
those reported in the literature [29–31], possibly due to
the limited availability of nutrients in the microchannels
[32].
Antibiotic Susceptibility Testing
We show in Fig. 3 how our method and device can
be used to determine the antibiotic susceptibility of bac-
teria rapidly and efficiently. We have tested bacterial
response to two antibiotics with different action mech-
anisms: ampicillin, a β-lactam bactericidal antibiotic,
and nalidixic acid, a bacteriostatic antibiotic at low
concentration. Prior to the microfluidic experiments,
the susceptibility of the bacteria and the minimum in-
hibitory concentration (MIC) values were determined
from resazurin-based microdilution ASTs (SI Appendix,
Supplemental Materials and Methods and Table S1).
Each data trace in Fig. 3 was collected on a separate de-
vice. All the results are presented in terms of the normal-
ized resistance change, ∆R(t)∆R(0) , i.e., the approximate num-
ber of bacteria in the microchannel as a function of time
normalized by the initial number of bacteria. In each
plot, the black curve shows the bacteria growth curve in
LB broth with no antibiotics. The different curves show
the results when bacteria are incubated in the presence
of different concentrations of different antibiotics.
Fig. 3A shows the effect of two different antibiotics,
ampicillin (red curves) and nalidixic acid (blue curves),
on motile E. coli. (The black curve is the growth curve
from Fig. 2B.) Our intial standardized ASTs confirm
that E. coli is susceptible to both antibiotics at the in-
dicated concentrations. In nalidixic acid, the measured
resistance is approximately constant over time (Fig. 3A
blue curves), suggesting that the bacteria does not grow
or change in any other way. In contrast, the electrical re-
sistance in ampicillin (Fig. 3A red curves) first increases
but then takes a turn, staying constant or decreasing be-
low the initial value. The behavior of the electrical resis-
tance, without resorting to microscopy, is consistent with
the fact that the cells elongate initially but cannot com-
plete their division and eventually die. The inset of Fig.
3A shows the growth rates r obtained from the normal-
ized resistance curves. Here, we compute ddt ln
[
∆R(t)
∆R(0)
]
within a sliding window of 20 mins in order to reduce the
numerical noise. The growth rates show that E. coli does
not grow appreciably in either antibiotic at the noted con-
centrations, suggesting the strain is susceptible to both
antibiotics. A straightforward metric for susceptibility
can be obtained by averaging the growth rate in the sec-
ond half of the test (i.e, last ∼ 1 hr). For this data set, we
obtain r¯G ≈ 0.019 min−1, r¯Amp ≈ −0.0037 min−1 and
r¯Nal ≈ −0.0017 min−1, all averaged over three measure-
ments. Thus, r¯ ≤ 0 can be taken as an objective — albeit
somewhat restrictive — condition for susceptibility. (In
Fig. 4 below, we look at different aspects of the same
data for differentiating between the action mechanisms
of these antibiotics.)
For K. pneumoniae (Fig. 3B), the normalized resis-
tance change in ampicillin (red curves) keeps increas-
ing with incubation time, while that in nalidixic acid
(blue curves) does not change at all. The inset shows
the growth rates as above. The data indicate that K.
pneumoniae is resistant to ampicillin but susceptible to
nalidixic acid at the indicated concentrations. We also
observe that the growth rate of K. pneumoniae in ampi-
cillin is lower than that with no drug. In the case of S.
saprophyticus (Fig. 3C ), the antibiotics cause different
outcomes.
We next determine the MICs for nalidixic acid and
ampicillin using our device and method. In an effort
to show the clinical relevance, we perform the MIC ex-
periments directly in bacteria-spiked human urine mixed
with LB broth. MICs are determined within a 2-hour
time window. Fig. 3D shows the normalized resis-
tance change as a function of time for K. pneumoniae
in nalidixic acid at concentrations of 0, 2, 4, 8, and 16
mg/L. Increasing the concentration of nalidixic acid slows
the growth down, eventually making the time derivative
negative at a concentration <∼ 16 mg/L (Fig. 3D), sug-
gesting that 16 mg/L can safely be taken as the MIC. The
corresponding growth rates in Fig. 3E are negative at
later times for the two highest antibiotic concentrations.
From Fig. 3F and G, we determine the MIC of ampi-
cillin for a non-motile strain of E. coli. The antibiotic
becomes effective at a concentration >∼ 4 mg/L but after
∼ 80 minutes of exposure. These MIC values and our
metric, r¯, remain consistent with results obtained from
standardized ASTs (SI Appendix, Table S1 and Table
S2).
Electrical Signatures of Antibiotic Mechanisms
We now take a more detailed look at the data presented
in Fig. 3A for motile E. coli in two antibiotics, focusing
on the short-time fluctuations of the resistance. We high-
pass filter the time-dependent resistance data, rejecting
drifts on time scales >∼ 100 seconds. Fig. 4A shows sam-
ples of these resistance fluctuations as a function of time
for ampicillin (red trace) and nalidixic acid (blue trace)
from single two-hour measurements; the black data trace
is collected in LB broth without bacteria. There ap-
pear to be more frequent and higher-amplitude resistance
fluctuations in ampicillin than nalidixic acid, with the
root-mean square (rms) values being δRamp ≈ 7.35 kΩ
and δRnal ≈ 0.93 kΩ during the two-hour measurement
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FIG. 3. (A-C) Electrical determination of the susceptibility of E. coli (A), K. pneumoniae (B), and S. saprophyticus (C )
to ampicillin and nalidixic acid. Normalized resistance changes as a function of incubation time under different conditions are
plotted for each strain. The black curve in each plot is the average growth curve in LB broth without antibiotics at 37◦C
from Fig. 2B, with the shaded region showing the standard deviation; the red and blue curves show the electrical signal in LB
broth with added ampicillin (10 mg/L) and nalidixic acid (20 mg/L), respectively, at 37◦C. Each colored curve represents one
independent experiment. Insets show the growth rate, r ≈ d
dt
ln
[
∆R(t)
∆R(0)
]
, calculated from the normalized resistance changes in
the main figure; each solid line and shaded region respectively show the average value and the standard deviation from three
experiments. (D-G) Determination of MIC. (D) Normalized resistance change for K. pneumoniae as a function of incubation
time in human urine with different concentrations of nalidixic acid. (E) Growth rates for each curve in (D). (F ) Determination
of ampicillin MIC for E. coli in human urine. (G) Growth rates for each curve in (F ).
(δRLB ≈ 0.52 kΩ). The inset on the left shows the fluc-
tuating signal in ampicillin on the timescale of a sin-
gle fluctuation. Simultaneous time-lapse microscope im-
ages (right inset) have allowed us to speculate about the
source of this particular fluctuation in ampicillin. The
images show that a bacterium in one of the 10 microchan-
nels undergo a rapid burst at roughly the same time as
the disappearance of the sharp electrical peak. We spec-
ulate that the swelling of the bacteria increases the re-
sistance before the burst, and the rapid burst gives rise
to the sudden resistance drop (SI Appendix, Movie S2).
The microscope images show that bacteria to the right
of the bursting bacterium are displaced even further and
some residue remains in the microchannel after the burst.
Bacteria in the other microchannels stay unchanged dur-
ing this time interval. We have not noticed many similar
cell bursting events in the 2-hour time-lapse images of
bacteria in nalidixic acid, which only inhibits cell divi-
sion.
To provide more quantitative insight into antibiotic
mechanisms, we calculate the probability density func-
tion (PDF) and the power spectral density (PSD) of the
resistance fluctuations. For this, we use all three data
sets for the same experiment, such as the ones in Fig.
4A. Fig. 4B shows the normalized PDFs in units of the
rms fluctuation amplitude. The black data are the PDF
of the background fluctuations collected in a device filled
with just LB broth. These background fluctuations are
for the most part Gaussian, with δRbg ≈ 0.52 kΩ. The
blue data obtained from E. coli in nalidixic acid starts to
deviate from a Gaussian and can be fitted by a stretched
exponential function. The red data in ampicillin with
the sharp peaks strongly deviates from a Gaussian. Fig.
4C shows the average power spectral densities (PSDs)
of these noise-like signals. The PSD of the signal in the
bacteriostatic antibiotic (blue) is close to the PSD of the
noise without bacteria. The added noise power due to
the bactericidal effect (red) is at low frequencies in the
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FIG. 4. Electrical signatures of action mechanisms of dif-
ferent antibiotics. (A) Time-dependent electrical resistance
fluctuations of E. coli in ampicillin (red trace) and nalidixic
acid (blue trace). The black curve shows the baseline fluc-
tuations in pure LB broth with no trapped bacteria. Insets
focus on a single peak along with microscope images recorded
at the indicated instants, with the scale bars being 5 µm.
(B) Normalized probability density functions (PDFs) plot-
ted in units of the rms values of the fluctuations. The black
dashed line is a Gaussian. The blue dashed line is a fit to
f(x) = A exp(− βx2
1+|x|ν ) with A = 0.93, β = 4.65, and ν =
1.78. The red dashed line is a fit to f(x) = A exp(−β | x|ν),
with A = 1.62, β = 2.85, and ν = 0.55. (C ) The average
power spectral densities (PSD) of the signals.
range 0.01 Hz to 0.5 Hz, which is the high-frequency cut-
off frequency in the measurement circuit. The 1/f -like
behavior of the PSD is probably due to the fact that
the bursts take place on different time scales. We further
compare the rms value of the fluctuations in ampicillin in
the first half with that in the second half of the two-hour
measurement, δR
(i)
amp ≈ 0.5δR(ii)amp, indicating that ampi-
cillin exhibits time-dependent bactericidal effect [33, 34].
DISCUSSION
This work describes an electrical approach that deter-
mines bacterial susceptibility to antibiotics in a microflu-
idic device. In the simplest interpretation, the approach
depends on the blockage of (quasi direct current) ionic
current by intact bacteria [35]. Upon further reflection,
however, deeper questions emerge on how ionic current
flows in pores and microchannels blocked by bacteria.
Some of our microscope images suggest that, after cell
lysis, the resistance tends to decrease even before the cell
residue gets washed out by the liquid flow. We spec-
ulate that, once the cell wall and membrane lose their
integrity, a bacterium may start to conduct ionic current
at a higher rate through the cell body. In the case of
rapid cell bursts, the residues are probably too small to
significantly block the ionic current efficiently.
At the current stage of development, the entire setup
consists of a basic Ohmmeter and a flow controller con-
nected to the microfluidic device. Given that the ap-
proach does not require a high-resolution microscope, it
could eventually be developed into a small and robust
point-of-care platform, potentially usable in resource-
limited settings. A few technical improvements are still
needed: First, the sample loading process could be opti-
mized. A higher applied pressure will allow the sample
to flow faster and reduce the loading time [17]. Cur-
rently, the pressure is limited by the bonding strength
between PDMS and the substrate. A silicon-based de-
vice, while harder to fabricate, may solve this problem.
Second, the electrical measurement can be multiplexed
to increase the throughput, reduce the test time, or pro-
vide the susceptibility of bacteria to multiple antibiotics
in parallel.
The fluctuations in the electrical signal due to antibi-
otic action are worth serious attention. The fluctuations
in the bacteriostatic antibiotic are close to those in LB
broth, with the slight increase in the rms amplitude pos-
sibly being due to the movements of the E. coli [36].
The more interesting question is the strong deviation
of the fluctuations in the bactericidal antibiotic exper-
iment from Gaussian statistics, approaching an exponen-
tial distribution. Apparently, the short strong and dis-
crete peaks generated by the cell bursts are responsible
for the observed behavior. This is reminiscent of wall
turbulence, where strong and rare turbulent wall bursts
completely dominate the velocity fluctuations in a similar
manner. A focused parametric experimental study and
a first-principles theory is needed for a more complete
biophysical picture.
In the short term, our method is poised to have clinical
relevance to UTI diagnosis and optimal treatment. While
this work lays the foundation for an antibiotic susceptibil-
ity test, further translational studies are needed for a clin-
ical test. Patients with UTIs and possible co-morbidities
7(e.g., diabetes, chronic renal disease) likely have complex
urine matrices that may not be directly usable in our de-
vice. However, uncomplicated UTI in otherwise healthy
adult women is one of the most common UTI syndromes
in outpatient medicine, and the need for rapid suscep-
tibility testing to improve empirical therapy is increas-
ing with more community-based gram negative resistance
[37]. Polymicrobial UTIs, in which multi-pathogens with
heterogeneous antibiotics response co-exist, may require
additional considerations.
MATERIALS & METHODS
Microfluidic Device
The microfluidic device consists of a PDMS mi-
crostructure (embedded with a two-layer microfluidic
channel) that is permanently bonded with a glass sub-
strate, which has metallic electrodes on it. We use stan-
dard soft lithography to fabricate the device. Details of
the device fabrication process are described in SI Ap-
pendix, Supplemental Materials and Methods.
Bacterial Strains, Growth Media and Antimicrobial
Preparations
In this study, motile E. coli (ATCC 25922), K. pneu-
moniae (ATCC 13883), S. saprophyticus (ATCC 15305)
were purchased from American Type Culture Collection
(ATCC, Manassas, VA), and non-motile E. coli (JW
1908-1) was obtained from E. coli Genetic Stock Center
(New Haven, CT). We used either Luria-Bertani (LB)
broth (Sigma-Aldrich, St. Louis, MO) or human urine
(Lee Biosolutions, Maryland Heights, MO) as growth me-
dia depending on the experiment. The stock solutions
of ampicillin and nalidixic acid were prepared using the
methods provided by the supplier (Alfa Aesar, Ward Hill,
MA). Details are provided in SI Appendix, Supplemental
Materials and Methods.
Electrical Measurements and Data Acquisition
A lock-in amplifier (SR 830 DSP, Stanford Research
Systems, Sunnyvale, CA) is used to measure the resis-
tances of the microchannels. The reference frequency
and time constant are 10 Hz and 300 ms (bandwidth
of ∼ 0.53 Hz), respectively. The output signals from
the lock-in amplifier were recorded using a data acquisi-
tion card (NI 6221, National Instruments, Austin, TX)
through a LabVIEW (National Instruments, Austin, TX)
Virtual Instrument (VI) interface. The sampling rate for
data collection is 6 Hz. The experimental data are an-
alyzed using Origin (MicroCal Software, Northampton,
MA) and MATLAB (Mathworks, Natick, MA). Details
of electrical measurements are given in SI Appendix, Sup-
plemental Materials and Methods.
Image Collection
Images of the bacterial cells in the microchannels were
obtained in an Axio observer inverted microscope (Carl
Zeiss, Jena, Germany) using a 63× objective, an Axio-
Cam 503 mono camera (Carl Zeiss, Oberkochen, Ger-
many), and ZEN image acquisition software (Carl Zeiss,
Jena, Germany).
Data Availability
All data and procedures are included in the
manuscript, SI Appendix, and Movies S1 and S2.
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SUPPLEMENTAL MATERIALS AND METHODS
DEVICE DESIGN AND FABRICATION
In designing the device, we used a first-pass optimization to determine the number k of parallel microchannels.
The throughput increases (and the loading time decreases) with increasing k. However, the available signal from a
microchannel is divided between k parallel resistors (see the resistance change calculation due to a single bacterium
below). The use of k = 10 parallel microchannels allowed us to achieve a loading time <∼ 30 min and to comfortably
observe resistance changes due to single cells.
Molds for the two-layer microfluidic channel are fabricated by patterning SU-8 photoresist (Microchem, Newton,
MA) onto a 4-inch silicon wafer. After mixing pre-polymer with cross-linker (Sylgard 184, Dow Corning, Midland,
MI) at a 9:1 ratio, the mixture is degassed in a vacuum desiccator for 30 minutes. Next, the bubble free PDMS
mixture is slowly poured onto the SU-8 mold and cured in a 90◦C oven for 1 hour. The slab of PDMS with the
embedded two-layer microfluidic channel structure is carefully peeled off from the master. Inlet and outlet ports (0.75
mm diameter) are mechanically punched into the PDMS using a biopsy punch. The PDMS structure and a glass
slide with pre-defined metallic electrodes are sterilized and bonded through oxygen plasma treatment. To fabricate
the chromium (Cr) and gold (Au) electrodes onto the glass slide, we use electron beam evaporation. The electrodes
are fabricated by evaporating a 90-nm-thick Au layer on top of a 60-nm-thick Cr adhesion layer.
BACTERIA CULTURING
First, lyophilized bacteria are re-solubilized and mixed gently with 1 mL of LB broth, and the solution is transferred
into 5 mL of LB broth for each bacterial strain. Next, the bacteria are grown in a shaking incubator at 37◦C and
100 rpm for 24 hours. After 24 hours, the turbid bacterial suspension is centrifuged for 6 minutes at 6000 rpm, and
the bacteria pellet is re-suspended in 5 mL of fresh LB broth. Finally, frozen stocks are prepared by dissolving highly
purified glycerol (MP Biomedicals, Solon, OH) at 20% v/v in PBS (Lonza BioWhittaker, Walkersville, MD), mixing
with bacterial suspension at 1:1 ratio, collecting into 200 µL aliquots and storing at −80◦C. On the day prior to
the experiment, a frozen stock is thawed, of which 150 µL is transferred into 8 mL of fresh LB broth; 10 µL of the
bacterial culture is streaked on a LB agar (Becton Dickinson, Sparks Glencoe, MD) plate and grown overnight to
check the purity of the bacterial culture. Bacteria are cultured overnight at 37◦C in a shaking incubator at 100 rpm.
On the day of the experiment, the bacteria culture is diluted to the desired concentration. We measure the optical
density of the culture at a wavelength of 600 nm (OD600) using a spectrophotometer (V-1200, VWR, Radnor, PA).
An OD600 of 0.1 corresponds to a bacterial cell density of 2× 107 CFU/mL, which is periodically confirmed through
serial dilution plating on LB agar plates.
RESAZURIN-BASED BROTH MICRODILUTION AST
In order to compare our method with standard methods, the susceptibility of E. coli, K. pneumoniae, and S. sapro-
phyticus are determined using resazurin-based broth miltidilution AST standardized by the Clinical and Laboratory
Standard Institute (CLSI). To ensure consistency, E. coli (ATCC 25922), for which the MICs of both ampicilin and
nalidixic acid are 4 mg/L [1], is used as a reference strain for all the resazurin-based microdilution tests. First,
ampicillin and nalidixic acid are diluted from stock solutions in LB broth. Column 12 of the 96-well plate is used as
growth control (no antibiotics); column 11 is used as sterility control (no bacteria); and columns 1-10 are filled with
solutions with decreasing antibiotic concentrations, which are prepared by using the two-fold serial dilution method.
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2Next, the bacterial cultures are prepared separately at 37◦C in 8 mL of LB broth. After adjusting their OD600 to 0.1,
the solution is further diluted by a factor of 20 with LB broth. Then, 100 µL of bacteria solution is added to each well
of columns 1 to 10, and column 12. The final bacterial concentration in each well is 5×105 CFU/mL. The bacterial
suspensions are used within 30 min after their optical density are adjusted to avoid changes of cell numbers [2]. Each
concentration is replicated in three wells in each plate. After incubating the plate at 37◦C in a shaking incubator at
100 rpm for 16-20 hours, 60 µL 0.015% solution of resazurin (ACROS Organics, New Jersey, USA) in tissue culture
grade water is added to each well and further incubated at 37◦C for another 4 hours. The plate results are read
by visual inspection of the wells. Dark blue/purple indicates that bacteria are not viable, and pink indicates that
bacteria are still viable. If the growth control shows dark blue/purple or the sterility control indicates contamination,
the plate is discarded. The MICs determined using the resazurin-based broth miltidilution AST are summarized in
Table S1.
EXPERIMENTAL PROTOCOL FOR ELECTRICAL MEASUREMENTS
We measure the growth of E. coli, K. pneumoniae, and S. saprophyticus in LB broth with and without antibiotics.
After adjusting an overnight bacterial culture to an OD600 of 0.1, the culture is diluted 1:20 into 5 mL LB broth and,
depending on the experiment, mixed with antibiotics in equal volume. This results in a final bacterial cell density of
5 × 105 CFU/mL. The mixture is transferred into a sterile 15-mL Falcon tube that is used as a sample reservoir. A
fluorinated ethylene propylene (FEP) tube (Cole-Parmer, Vernon Hills, IL) is used to connect the sample reservoir
to the microfluidic device inlet. During sample loading, the inlet is pressurized at ∆p ∼ 10 kPa above the outlet.
The number of trapped bacteria is typically not uniform across microchannels. After approximately tens of bacteria
are trapped in the microchanels, voltage drop across the microchannels is measured to quantify the bacterial growth.
During the measurements, the pressure difference between inlet and outlet is maintained at ∆p ∼ 0.5 kPa. The
pressure during loading is controlled using a pressure controller (OB1-Mk3, Elveflow, Paris, France). To ensure a
stable temperature of the microfluidic device during an experiment, a PeCon 20002 Temp Controller (PeCon GmbH,
Erbach, Germany) is used. To show that our microfluidic device can be used to determine MICs for antibiotics in
human urine samples, we measure K. pneumoniae in nalidixic acid and E. coli (non-motile) in ampicillin. Bacteria
concentration is adjusted to an OD600 of 0.1, and the bacteria solution is diluted 1:20 in 5 mL of human urine sample.
Subsequently, the bacteria-spiked urine samples are mixed with LB broth and nalidixic acid (0, 4, 8, 16, and 32 mg/L)
or ampicillin (0, 2, 4, 8, and 16 mg/L) in equal volume prior to loading into a microfluidic device.
ELECTRICAL MEASUREMENTS
Fig. S1 shows the simplified equivalent circuit model of the electrical measurement. The lock-in amplifier oscillator
output Vs (rms amplitude of 1 V and reference frequency of fr = 10 Hz) is connected to a resistor Rs = 100 MΩ to
create a current source, which drives a current (several nA) through the device and the input circuit of the lock-in.
The input resistance of the lock-in amplifier is 10 MΩ. We use a four-wire measurement to measure the resistance
of the device. At fr = 10 Hz, the four-wire electrical impedance of the device is dominated by its resistance; typical
device impedance at the start of each experiment is ≈ 3 − 0.2i MΩ, corresponding to a phase angle of −4o. The
resistance value and the phase both drift over the course of two hours. The drift in the resistance is <∼ 1% and the
impedance phase angle is ±1o. We estimate each contact impedance to be ≈ 70− 700i kΩ at 10 Hz through two-wire
measurements. We use a 300 ms time constant on the lock-in amplifier and digitally sample the data from the lock-in
at a rate of 6 Hz. When we focus on the long-term behavior of the resistance (e.g., growth or antibiotic susceptibility
measurements over two hours), we further integrate (average) the data numerically over one-minute intervals. When
we focus on the short-time fluctuations (i.e., Fig. 4 in main text), we high-pass filter the data using a cut-off frequency
of 0.01 Hz.
The time-dependent resistance of the device can be expressed as R(t) = Rem + ∆R(t), where Rem is the initial
resistance of the microchannels with pure LB broth and ∆R(t) is the resistance change induced by bacteria in the
microchannels. We can estimate the minimum detectable ∆R from noise analysis. In the experiments, the equivalent
noise bandwidth at a time constant of 300 ms is ∆f ≈ 0.31 Hz (time constant 300 ms and filter roll-of 18 dB/oct). To
determine the experimental noise floor, we perform a noise measurement using a 3.2 MΩ source resistor. We obtain
a total noise of ∼ 600 nV/Hz1/2. This value is slightly larger than the theoretical value of ∼ 300 nV/Hz1/2, obtained
from combining the Johnson noise of a 3.2 MΩ resistor (230 nV/Hz1/2) with the input noise, V
(a)
n , of the lock-in at
10 Hz (V
(a)
n
<∼ 200 nV/Hz1/2). We use a low-sensitivity setting on the lock-in to be able to track the large changes in
3the device resistance during bacteria growth. The minimum detectable resistance change or the resistance noise can
be estimated from a simple circuit analysis. Here, we assume that the minimum detectable resistance change (under
the imposed current of 10 nA across the device and the lock-in input) results in a voltage equal to the noise voltage.
This provides ≈ 200 Ω, which is close to the resistance fluctuations (noise) observed in LB broth.
In order to quantify the effect of the long-term electrical drifts on the sensitivity, we have performed a set of
experiments using devices clogged with 1-µm-diameter polystyrene (PS) microspheres. This is similar to clogging the
microchannels with bacteria but, since the PS microspheres do not change in size over time, we are able to extract the
electrical drift under conditions comparable to bacteria experiments. In particular, we clog the devices to resistance
values R(0) (or ∆R(0)) close to those in bacteria experiments, indicating similar flow rates and initial conditions.
Three baseline resistance drifts measured over the course of 2 hours are shown in Fig. S2A. Since the drift appears
linear, we fit it as ∆R(t) −∆R(0) ≈ −0.26t (in units of kΩ when t is in minutes). In an effort to quantify the drift
effect on the antibiotic susceptibility tests, we have recalculated the drift-corrected growth rates (dashed lines in Fig.
S2B-F ). Here, the solid lines are the results from Fig. 3 in the main text. In the recalculation, we first subtracted
the drift from each data trace and then computed the growth rate. Our conclusion, after comparing the growth rates
of corrected and raw data in Table S2, is that drift can safely be neglected at this stage of development.
RESISTANCE CHANGE PER ADDED BACTERIUM
We show the resistance change ∆R as a function of the number n of bacteria in the microchannels for K. pneumoniae,
E. coli, and S. saprophyticus in Fig. S3. Data shown in each figure are from three independent experiments. Red
dashed lines are the linear fits to the data. We obtain ∆R
(KP )
1 ≈ 2.5 ± 0.3 kΩ for K. pneumoniae (Fig. S3A),
∆R
(EC)
1 ≈ 3.7 ± 0.3 kΩ for E. coli (Fig. S3B), and ∆R(SS)1 ≈ 3.5 ± 1.1 kΩ per S. saprophyticus (Fig. S3C ). The
larger error in S. saprophyticus originates from the fact that it is more challenging to count single cells from microscope
images and cells tend to cluster more.
The measured Rem is the equivalent resistance of ten parallel microchannels at the center of the microfluidic device:
Rem =
1
10R
(s)
em, where R
(s)
em is the single microchannel resistance, R
(s)
em = ρ
l
A , with ρ being the electrical resistivity of the
liquid media (e.g., LB broth) filling the microchannel, l and A being respectively the length and cross-sectional area of
the single microchannel. We assume that the electrical resistance of bacteria is large compared to the media. Thus, the
resistance of a single microchannel with one trapped bacterium can be estimated as R
(s)
em+∆R
(s)
1 ≈ ρ
[
l−lB
A +
lB
A−AB
]
,
where lB and AB are the length and cross-sectional area of a bacterium, respectively. Here, Rem ≈ 3 MΩ in LB broth,
which, using the nominal channel dimensions, gives ρ ≈ 1.2 Ω · m. K. pneumoniae is rod-shaped, with lB = 2 µm
and AB = 0.8 µm
2 [3]. Using these numbers, we obtain ∆R
(s)
1 ≈ 150 kΩ. Calculating the equivalent resistance, we
find the total resistance change per bacterium becomes ∆R1 ≈ ∆R
(s)
1
100 ≈ 1.5 kΩ. Note that the resistance change per
bacterium very much depends on the size of the bacterium and how the bacterium blocks the microchannel during
growth. It is thus different for S. saprophyticus and E. coli.
BACTERIA ACCUMULATION OR GROWTH OUTSIDE OF THE MICROCHANNELS
We occasionally observe bacteria accumulation outside of the microchannels or growth outward. Fig. S4 shows
two different non-ideal ways bacteria accumulate in the device. The linear dimensions of the regions immediately
upstream and downstream from the microchannels are l × w × h ≈ 75 × 80 × 2 µm3. The microscope images in
Fig. S4 show a portion of this region in addition to the central microchannels. Fig. S4A shows that bacteria (E.
coli) can get immobilized in the inlet region; in addition, any bacteria that escapes through the nanoconstriction can
proliferate in the outlet region. Fig. S4B shows that bacteria (S. saprophyticus) can get stuck at the entry region
of the microchannels, blocking further bacteria trapping in the microchannels. When bacteria are trapped in these
bigger channels (l × w × h ≈ 75 × 80 × 2 µm3), the resistance change per added bacterium no longer follows the
ideal case discussed in the main text. In fact from geometry, the resistance change per bacterium is ∼ 120∆R1, where
∆R1 ≈ 1.5 kΩ is the resistance change per added bacterium into one of the ten smaller microchannels, as discussed
above. For bacteria accumulating outside of this 2-µm-high region, the resistance change is even smaller. Thus,
our measured resistance signals mainly come from the ten smaller microchannels. We note that bacteria trapped
outside the microchannels also grow (or die). Thus, their signals are coherently added to the signals developing in the
microchannels. Finally, if the experiment continues for a long time, bacteria, especially motile strains, tend to escape
more readily and/or grow outward after filling the microchannels.
4ESTIMATION OF BACTERIAL DOUBLING TIME
We have estimated the doubling time td of bacteria using resistance change data during growth. As discussed in
the main text, ∆R(t)∆R(0) ≈ n(t)n(0) = e
ln 2
td
t
. Thus, td can be obtained by a linear fit to the natural logarithm of
∆R(t)
∆R(0) . Fig.
S5 shows a number of fits (dashed lines) to the experimental resistance data (solid lines) for E. coli, K. pneumoniae,
and S. saprophyticus. Each curve is from an independent experiment. The td and R
2 values are as indicated in the
figure.
DATA FROM ALL MEASUREMENTS
Fig. S6 shows the resistance change, ∆R(t) − ∆R(0) = R(t) − R(0), measured over the course of 2 hours after
sample loading in all our antibiotic susceptibility tests and growth experiments. For each data plot, the right y axis
shows the change in the number of bacteria in the device, ∆n(t), which is estimated from ∆n(t) = ∆R(t)−∆R(0)∆R1 with
∆R1 being the calibration value from Fig. S3. The initial resistances R(0) measured at the start of each electrical
measurement are shown in Table S3. The approximate number of trapped bacteria in the microchannels at the start
of each electrical measurement from microscope images are listed in Table S4.
METRIC FOR ASSESSING ANTIBIOTIC SUSCEPTIBILITY
A simple metric for aility can be obtained from the time derivative of the resistance data, ddt ln
[
∆R(t)
∆R(0)
]
. Given
that ∆R(t)∆R(0) ≈ n(t)n(0) and n(t) ≈ n(0)ert, ddt ln
[
∆R(t)
∆R(0)
]
≈ r. If r > 0, the population grows; if r ≤ 0, the population
does not grow. Since r itself is a function of time, especially for antibiotics acting with some delay, it may be more
appropriate to consider r averaged over roughly the second half of the experiment. Thus, we calculate r¯ averaged over
the last 40 mins of available data, which corresponds to the last 60 mins of the resistance measurement due to the
20-min time window of the derivative. Table S2 shows r¯ values in all experiments calculated from raw data as well as
drift-corrected data (Fig. S2B-F ). This metric provides conclusions consistent with standard AST results. We note,
however, that r¯ ≤ 0 may be too restrictive a condition for susceptibility, especially for a clinical application. More
data and error analysis may allow us to relax this condition to r¯ ≤ ε, where ε > 0.
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FIG. S1: Equivalent-electrical circuit for the measurement. The dashed boxes represent the lock-in amplifier; V
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n is the input
noise voltage and G is the gain of the lock-in amplifier.
6BA
D
F
C
E
0 40 80 120
-40.0k
-20.0k
0.0
 y = -0.26x
∆
R
(t)
 - 
∆
R
(0
) [
Ω
]
Time [min]
G
ro
w
th
 ra
te
 [m
in
-1
]
G
ro
w
th
 ra
te
 [m
in
-1
]
G
ro
w
th
 ra
te
 [m
in
-1
]
G
ro
w
th
 ra
te
 [m
in
-1
]
G
ro
w
th
 ra
te
 [m
in
-1
]
0 25 50 75 100
-0.04
-0.02
0.00
0.02
Time [min]
Growth
1 mg/
2 mg/L 
4 mg/L
8 mg/L
0 25 50 75 100
0.00
0.01
0.02
Time [min]
Growth
Amp
Nal
0 25 50 75 100
-0.01
0.00
0.01
Time [min]
Growth
Amp
Nal
0 25 50 75 100
0.00
0.01
0.02
0.03
Time [min]
Growth
Amp
Nal
0 25 50 75 100
0.00
0.01
0.02
Growth
2 mg/L
Time [min]
4 mg/L
8 mg/L
16 mg/L
FIG. S2: (A) Baseline drifts as a function of time in three independent experiments; the red dashed line shows the linear fit.
(B-F ) Growth rates from raw (solid lines) and drift-corrected resistance data (dashed lines). Solid lines are reproduced from
Fig. 3 in the main text.
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FIG. S4: Microscope snapshots showing bacteria accumulation outside the microchannels. (A) E. coli (ATCC 25922) growing
in LB broth in nalidixic acid (20 mg/L). The bacteria that escaped through the nanoconstriction have proliferated in the outlet
region. (B) S. saprophyticus (ATCC 15305) growing in LB broth in ampicillin (10 mg/L). Some cells have accumulated at the
entry regions of the microchannels. The scale bars are 5 µm.
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FIG. S5: Linear fits to the natural logarithm of ∆R(t)
∆R(0)
in order to determine the bacterial doubling time in the microchannels.
(A) E. coli (ATCC 25922) at 37 ◦C. (B) K. pneumoniae (ATCC 13883) at 37 ◦C. (C ) S. saprophyticus (ATCC 15305) at
37 ◦C. (D) E. coli (ATCC 25922) at 23 ◦C. Solid lines show data from independent experiments; the dashed lines show the
linear fits.
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FIG. S6: Measured resistance change ∆R(t)−∆R(0) and change in the number of bacteria, ∆n(t), in the microchannels after
sample loading as a function of time. Measurements on E. coli (ATCC 25922) (A-C ), K. pneumoniae (ATCC 13883) (D-F ),
S. saprophyticus (ATCC 15305) (G-I ). (J ) Measurements on E. coli (ATCC 25922) in PBS at 37◦C and LB broth at 23◦C and
37◦C. (K ) Measurements on K. pneumoniae (ATCC 13883) growing in urine with nalidixic acid at different concentrations.
(L) Measurement on E. coli (JW 1908-1) growing in urine with ampicillin at different concentrations. Each curve represents
one independent experiment.
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TABLE S1: Summary of MICs of ampicillin and nalidixic acid for E. coli, K. pnuemoniae and S. saprophyticus obtained by
resazurin-based broth multidilution AST. Results obtained in urine are shown in parentheses.
Bacteria Ampicillin (mg/L) Nalidixic acid (mg/L)
E. coli (ATCC 25922) 8 4-8
K. pnuemoniae (ATCC 13883) > 128 16 (8)
S. saprophyticus (ATCC 15305) < 0.25 > 128
E. coli (JW 1908-1) (4) -
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TABLE S2: Average growth rates r¯ for all experiments without and with drift correction. Where available, both the average
values and the results of individual experiments (in parentheses) are tabulated.
Bacteria Antibiotic Expectation r¯ (min−1) Drift-corr. r¯ (min−1)
E. coli Growth (LB) - 0.019 (0.021, 0.018, 0.019) 0.019 (0.021, 0.018, 0.019)
E. coli Ampicillin, 10 mg/L Susceptible -0.0037 (-0.0005, -0.0099, -0.0006) -0.0027 (0.0003, -0.0093, 0.0008)
E. coli Nalidixic acid, 20 mg/L Susceptible -0.0017 (-0.0011, 0.0012, -0.0052) -0.0008 (-0.0005, 0.0023, -0.0043)
K. pnuemoniae Growth (LB) - 0.021 (0.022, 0.026, 0.015) 0.021 (0.022, 0.026, 0.015)
K. pnuemoniae Ampicillin, 10 mg/L Resistant 0.0114 (0.0096, 0.0176, 0.0070) 0.0118 (0.0099, 0.0184, 0.0071)
K. pnuemoniae Nalidixic acid, 20 mg/L Susceptible -0.0019 (-0.0044, 0.0013, -0.0027) -0.0010 (-0.0034, 0.0019, -0.0014)
S. saprophyticus Growth (LB) - 0.010 (0.007, 0.015, 0.009) 0.010 (0.007, 0.015, 0.009)
S. saprophyticus Ampicillin, 10 mg/L Susceptible -0.0096 (-0.0058, -0.0068, -0.0161) -0.0071 (-0.0039, -0.0051, -0.0124)
S. saprophyticus Nalidixic acid, 20 mg/L Resistant 0.0059 (0.0052, 0.0055, 0.0069) 0.0064 (0.0057, 0.0062, 0.0072)
K. pnuemoniae Growth (urine) - 0.018 0.018
K. pnuemoniae Nalidixic acid, 2 mg/L Resistant 0.018 0.018
K. pnuemoniae Nalidixic acid, 4 mg/L Resistant 0.0059 0.0062
K. pnuemoniae Nalidixic acid, 8 mg/L Resistant 0.0006 0.0012
K. pnuemoniae Nalidixic acid, 16 mg/L Susceptible -0.0008 -0.0002
E. coli Growth (urine) - 0.013 0.013
E. coli Ampicillin, 1 mg/L Resistant 0.017 0.017
E. coli Ampicillin, 2 mg/L Resistant 0.0125 0.0126
E. coli Ampicillin, 4 mg/L Susceptible -0.0232 -0.0197
E. coli Ampicillin, 8 mg/L Susceptible -0.0193 -0.0136
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TABLE S3: Initial resistances R(0) for each electrical measurement. Experiments in urine are shown in parentheses.
Bacteria Growth (MΩ) Ampicillin (MΩ) Nalidixic acid (MΩ)
E. coli ATCC 25922 4.02, 4.10, 4.15 3.47, 3.95, 3.99 3.59, 3.24, 3.59
K. pnuemoniae ATCC 13883 3.22, 3.15, 3.46 3.65, 3.47, 3.91 3.41, 3.55, 3.28 (3.24, 3.21, 3.52, 3.45, 3.60)
S. saprophyticus ATCC 15305 3.28, 3.22, 3.24 3.29, 3.37, 3.19 3.28, 3.16, 3.43
E. coli JW 1908-1 - (3.23, 3.27, 3.26, 3.18, 3.16) -
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TABLE S4: Rough number of bacteria trapped in the microchannel region in each experiment as determined from microscope
images. Experiments in urine are shown in parentheses.
Bacteria Growth Ampicillin Nalidixic acid
E. coli (ATCC 25922) 90, 95, 95 70, 95, 95 75, 50, 75
K. pnuemoniae (ATCC 13883) 60, 50, 85 85, 65, 95 60, 70, 50 (60, 60, 70, 65, 80)
S. saprophyticus (ATCC 15305) 60, 60, 50 45, 60, 45 40, 50, 65
E. coli (JW 1908-1) - (60, 55, 40, 30, 35) -
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SUPPLEMENTAL MOVIES
Movies S1. E.coli (ATCC 25922) growth with no drug in the microchannels in LB broth at 37◦C. (Left) Time-lapse
imaging showing that the cells are immobilized and growing in the microchannels. Scale bar, 5 µm. (Right) The
normalized electrical resistance change ∆R(t)∆R(0) of the microchannels as a function of time. Each second in the video
corresponds to ∼ 3 min in the experiment.
Movies S2. E. coli (ATCC 25922) growth in the presence of ampicillin (10 mg/L) in the microchannels in LB broth
at 37◦C. (Left) Time-lapse images show that the trapped cells are elongating and swelling, but do not divide, and
finally burst in the microchannels. Scale bar, 5 µm. (Right) The normalized electrical resistance change ∆R(t)∆R(0) and
the resistance fluctuations of the microchannels as a function of time. Each second in the video corresponds to ∼ 3
min in the experiment.
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